Kevin G. Lafond
2013
In 2013, Kevin G. Lafond earned a total compensation of $347.8K as Vice President - Finance, Chief Accounting Officer and Treasurer at ZIOPHARM Oncology.
Compensation breakdown
| Bonus | $35,126 |
|---|---|
| Option Awards | $116,746 |
| Salary | $195,142 |
| Other | $749 |
| Total | $347,763 |
Lafond received $195.1K in salary, accounting for 56% of the total pay in 2013.
Lafond also received $35.1K in bonus, $116.7K in option awards and $749 in other compensation.
Rankings
In 2013, Kevin G. Lafond's compensation ranked 10,449th out of 12,286 executives tracked by ExecPay. In other words, Lafond earned more than 15.0% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 10,449 out of 12,286 | 15th |
Division Manufacturing | 3,895 out of 4,612 | 16th |
Major group Chemicals And Allied Products | 1,239 out of 1,466 | 16th |
Industry group Drugs | 976 out of 1,160 | 16th |
Industry Pharmaceutical Preparations | 758 out of 890 | 15th |
Source: SEC filing on April 30, 2014.
Lafond's colleagues
We found four more compensation records of executives who worked with Kevin G. Lafond at ZIOPHARM Oncology in 2013.